328 related articles for article (PubMed ID: 34247752)
1. Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
Law S; Fontana M; Gillmore JD
Cardiol Clin; 2021 Aug; 39(3):389-402. PubMed ID: 34247752
[TBL] [Abstract][Full Text] [Related]
2. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
Griffin JM; Maurer MS
Trends Cardiovasc Med; 2021 Jan; 31(1):59-66. PubMed ID: 31889610
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: A position statement of the Polish Cardiac Society.
Grzybowski J; Podolec P; Holcman K; Gawor-Prokopczyk M; Jankowska E; Kostkiewicz M; Dąbrowska-Kugacka A; Lipowska M; Mazurkiewicz Ł; Rajtar-Salwa R; Rubiś P; Straburzyńska-Migaj E; Szczygieł J; Mitkowski P
Kardiol Pol; 2023; 81(11):1167-1185. PubMed ID: 37768101
[TBL] [Abstract][Full Text] [Related]
4. When to Suspect and How to Approach a Diagnosis of Amyloidosis.
Law S; Gillmore JD
Am J Med; 2022 Apr; 135 Suppl 1():S2-S8. PubMed ID: 35081377
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies.
Yadav JD; Othee H; Chan KA; Man DC; Belliveau PP; Towle J
Ann Pharmacother; 2021 Dec; 55(12):1502-1514. PubMed ID: 33685242
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
7. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
8. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
[TBL] [Abstract][Full Text] [Related]
9. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
10. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
[TBL] [Abstract][Full Text] [Related]
11. Updates in Cardiac Amyloidosis Diagnosis and Treatment.
Stern LK; Kittleson MM
Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy.
Teng C; Li P; Bae JY; Pan S; Dixon RAF; Liu Q
Clin Cardiol; 2020 Nov; 43(11):1223-1231. PubMed ID: 32725834
[TBL] [Abstract][Full Text] [Related]
13. Advances in the diagnosis and treatment of transthyretin amyloid cardiomyopathy.
Vaishnav J; Brown E; Sharma K
Prog Cardiovasc Dis; 2024; 82():113-124. PubMed ID: 38246305
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Amyloidosis Treatment.
Stern LK; Patel J
Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
[TBL] [Abstract][Full Text] [Related]
15. Opportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis.
Martyn T; Rubio AC; Estep JD; Hanna M
Methodist Debakey Cardiovasc J; 2022; 18(5):27-39. PubMed ID: 36561083
[TBL] [Abstract][Full Text] [Related]
16. Monitoring cardiac amyloidosis with multimodality imaging.
Starr N; Ioannou A; Martinez-Naharro A
Rev Esp Cardiol (Engl Ed); 2024 Jan; 77(1):79-87. PubMed ID: 37696332
[TBL] [Abstract][Full Text] [Related]
17. Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy.
Porcari A; Sinagra G; Gillmore JD; Fontana M; Hawkins PN
Eur J Intern Med; 2024 May; 123():29-36. PubMed ID: 38184468
[TBL] [Abstract][Full Text] [Related]
18. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).
Brito D; Albrecht FC; de Arenaza DP; Bart N; Better N; Carvajal-Juarez I; Conceição I; Damy T; Dorbala S; Fidalgo JC; Garcia-Pavia P; Ge J; Gillmore JD; Grzybowski J; Obici L; Piñero D; Rapezzi C; Ueda M; Pinto FJ
Glob Heart; 2023; 18(1):59. PubMed ID: 37901600
[TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
20. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Gillmore JD; Maurer MS; Falk RH; Merlini G; Damy T; Dispenzieri A; Wechalekar AD; Berk JL; Quarta CC; Grogan M; Lachmann HJ; Bokhari S; Castano A; Dorbala S; Johnson GB; Glaudemans AW; Rezk T; Fontana M; Palladini G; Milani P; Guidalotti PL; Flatman K; Lane T; Vonberg FW; Whelan CJ; Moon JC; Ruberg FL; Miller EJ; Hutt DF; Hazenberg BP; Rapezzi C; Hawkins PN
Circulation; 2016 Jun; 133(24):2404-12. PubMed ID: 27143678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]